Gene duplication of coagulation factor V and origin of venom prothrombin activator in Pseudonaja textilis snake

Thrombosis and Haemostasis

Volumn 93, Issue 3, 2005, Pages 420-429

  Le, Thi Nguyet Minh ^a   Reza, Md Abu ^a   Swarup, Sanjay ^a   Kini, R Manjunatha ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coagulation factor V; Gene duplication; Pseudonaja textilis; Venom toxin evolution

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5A; COMPLEMENTARY DNA; PROTHROMBIN; PSEUTARIN C; SNAKE VENOM; THROMBIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CATALYSIS; COMPLEX FORMATION; CONTROLLED STUDY; DISULFIDE BOND; DNA SEQUENCE; GENE DUPLICATION; GENE EXPRESSION; HEMOSTASIS; LIVER LEVEL; MOLECULAR CLONING; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SNAKE; SULFATION; TISSUE SPECIFICITY;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; DITERPENES; ELAPID VENOMS; ELAPIDAE; EVOLUTION, MOLECULAR; FACTOR V; GENE DUPLICATION; LIVER; MOLECULAR SEQUENCE DATA; PEPTIDE HYDROLASES; PROTEIN C; PROTEIN PROCESSING, POST-TRANSLATIONAL; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 15344341825     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH04-11-0707     Document Type: Article

References (52)

1. Suttie JW, Jackson CM. Prothrombin structure, activation, and biosynthesis. Physiol Rev 1977; 57: 1-70.
2. Rosing J, Tans G, Govers-Riemslag JW, et al. The role of phospholipids and factor Va in the prothrombinase complex. J Biol Chem 1980; 255: 274-83.
3. van Rijn JL, et al. Kinetic studies of prothrombin activation: effect of factor Va and phospholipids on the formation of the enzyme-substrate complex. Biochemistry 1984; 23: 4557-64.
4. Mann KG, et al. Cofactor proteins in the assembly and expression of blood clotting enzyme complexes. Annu Rev Biochem 1988; 57: 915-56.
5. Nesheim ME, Taswell JB, Mann KG. The contribution of bovine Factor V and Factor Va to the activity of prothrombinase. J Biol Chem 1979; 254: 10952-62.
6. Boskovic DS, Giles AR, Nesheim ME. Studies of the role of factor Va in the factor Xa-catalyzed activation of prothrombin, fragment 1.2-prethrombin-2, and dansyl-L-glutamyl-glycyl-L-arginine-meizothrombin in the absence of phospholipid. J Biol Chem 1990; 265: 10497-505.
7. Krishnaswamy S, Church WR, Nesheim ME, et al. Activation of human prothrombin by human prothrombinase. Influence of factor Va on the reaction mechanism. J Biol Chem 1987; 262: 3291-9.
8. Boskovic DS, Bajzar LS, Nesheim ME. Channeling during prothrombin activation. J Biol Chem 2001; 276: 28686-93.
9. Hutton RA, Warrell DA. Action of snake venom components on the haemostatic system. Blood Rev 1993; 7: 176-89.
10. Markland FS, Jr. Snake venoms. Drugs 1997; 54 Suppl 3: 1-10.
11. Kini RM, Morita T, Rosing J. Classification and nomenclature of prothrombin activators isolated from snake venoms. Thromb Haemost 2001; 86: 710-1.
12. Masci PP, Whitaker AN, de Jersey J. Purification and characterization of a prothrombin activator from the venom of the Australian brown snake, Pseudonaja textilis textilis. Biochem Int 1988; 17: 825-35.
13. Rao VS, Kini RM. Pseutarin C, a prothrombin activator from Pseudonaja textilis venom: its structural and functional similarity to mammalian coagulation factor Xa-Va complex. Thromb Haemost 2002; 88: 611-9.
14. Speijer H, et al. Prothrombin activation by an activator from the venom of Oxyuranus scutellatus (Taipan snake). J Biol Chem 1986; 261: 13258-67.
15. Rao VS, Swarup S, Kini RM. The nonenzymatic subunit of pseutarin C, a prothrombin activator from eastern brown snake (Pseudonaja textilis) venom, shows structural similarity to mammalian coagulation factor V. Blood 2003; 102: 1347-54.
16. Joseph JS, et al. Effect of snake venom procoagulants on snake plasma: implications for the coagulation cascade of snakes. Toxicon 2002; 40: 175-83.
17. Kane WH, Majerus PW. Purification and characterization of human coagulation factor V. J Biol Chem 1981; 256: 1002-7.
18. Takahashi N, Bauman RA, Ortel TL, et al. Internal triplication in the structure of human ceruloplasmin. Proc Natl Acad Sci U S A 1983; 80: 115-9.
19. Adams TE, Hockin MF, Mann KG, et al. The crystal structure of activated protein C-inactivated bovine factor Va: Implications for cofactor function. Proc Natl Acad Sci U S A 2004; 101: 8918-23.
20. Zeibdawi AR, et al. Coagulation factor Va Glu-96-Asp-111: a chelator-sensitive site involved in function and subunit association. Biochem J 2004; 377: 141-8.
21. Kalafatis M, Mann KG. The role of the membrane in the inactivation of factor va by plasmin. Amino acid region 307-348 of factor V plays a critical role in factor Va cofactor function. J Biol Chem 2001; 276: 18614-23.
22. Kalafatis M, Beck DO. Identification of a binding site for blood coagulation factor Xa on the heavy chain of factor Va. Amino acid residues 323-331 of factor V represent an interactive site for activated factor X. Biochemistry 2002; 41: 12715-28.
23. Poole S, Firtel RA, Lamar E, et al. Sequence and expression of the discoidin I gene family in Dictyostelium discoideum. J Mol Biol 1981; 153: 273-89.
24. Nicolaes GA, Villoutreix BO, Dahlback B. Mutations in a potential phospholipid binding loop in the C2 domain of factor V affecting the assembly of the prothrombinase complex. Blood Coagul Fibrinolysis 2000; 11: 89-100.
25. Guinto ER, Esmon CT, Mann KG, et al. The complete cDNA sequence of bovine coagulation factor V. J Biol Chem 1992; 267: 2971-8.
26. Jenny RJ, Pittman DD, Toole JJ, et al. Complete cDNA and derived amino acid sequence of human factor V. Proc Natl Acad Sci U S A 1987; 84: 4846-50.
27. Yang TL, Cui J, Rehumtulla A, et al. The structure and function of murine factor V and its inactivation by protein C. Blood 1998; 91: 4593-9.
28. Nazarenko IA, Bhatnagar SK, Hohman RJ. A closed tube format for amplification and detection of DNA based on energy transfer. Nucleic Acids Res 1997; 25: 2516-21.
29. Nesheim ME, Mann KG. Thrombin-catalyzed activation of single chain bovine factor V. J Biol Chem 1979; 254: 1326-34.
30. Thorelli E, Kaufman RJ, Dahlback B. Cleavage requirements for activation of factor V by factor Xa. Eur J Biochem 1997; 247: 12-20.
31. Steen M, Dahlback B. Thrombin-mediated proteolysis of factor V resulting in gradual B-domain release and exposure of the factor Xa-binding site. J Biol Chem 2002; 277: 38424-30.
32. Kalafatis M, Beck DO, Mann KG. Structural requirements for expression of factor Va activity. J Biol Chem 2003; 278: 33550-61.
33. Orfeo T, Brufatto N, Nesheim ME, et al. The factor v activation paradox. J Biol Chem 2004; 279: 19580-91.
34. Kalafatis M, Rand MD, Mann KG. The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem 1994; 269: 31869-80.
35. Mann KG, Hockin MF, Begin KJ, et al. Activated protein C cleavage of factor Va leads to dissociation of the A2 domain. J Biol Chem 1997; 272: 20678-83.
36. Esmon CT. Role of coagulation inhibitors in inflammation. Thromb Haemost 2001; 86: 51-6.
37. Nicolaes GA, et al. Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein C. J Biol Chem 1995; 270: 21158-66.
38. Kalafatis M, Mann KG. Role of the membrane in the inactivation of factor Va by activated protein C. J Biol Chem 1993; 268: 27246-57.
39. van der Neut KM, Dirven RJ, Vos HL, et al. Factor Va is inactivated by activated protein C in the absence of cleavage sites at Arg-306, Arg-506, and Arg-679. J Biol Chem 2004; 279: 6567-75.
40. Nesheim ME, Canfield WM, Kisiel W, et al. Studies of the capacity of factor Xa to protect factor Va from inactivation by activated protein C. J Biol Chem 1982; 257: 1443-7.
41. Xue J, Kalafatis M, Mann KG. Determination of the disulfide bridges in factor Va light chain. Biochemistry 1993; 32: 5917-23.
42. Xue J, Kalafatis M, Silveira JR, Kung C, Mann KG. Determination of the disulfide bridges in factor Va heavy chain. Biochemistry 1994; 33: 13109-16.
43. Bruin T, Sturk A, ten Cate JW, et al. The function of the human factor V carbohydrate moiety in blood coagulation. Eur J Biochem 1987; 170: 305-10.
44. Thorelli E, Kaufman RJ, Dahlback B. The C-terminal region of the factor V B-domain is crucial for the anticoagulant activity of factor V. J Biol Chem 1998; 273: 16140-5.
45. Kalafatis M. Identification and partial characterization of factor Va heavy chain kinase from human platelets. J Biol Chem 1998; 273: 8459-66.
46. Hortin GL. Sulfation of tyrosine residues in coagulation factor V. Blood 1990; 76: 946-52.
47. Pittman DD, Tomkinson KN, Michnick D, et al. Posttranslational sulfation of factor V is required for efficient thrombin cleavage and activation and for full procoagulant activity. Biochemistry 1994; 33: 6952-9.
48. Rao VS, Swarup S, Manjunatha KR. The catalytic subunit of pseutarin C, a group C prothrombin activator from the venom of Pseudonaja textilis, is structurally similar to mammalian blood coagulation factor Xa. Thromb Haemost 2004; 92: 509-21.
49. Ogawa T, Onoue H, Nakagawa K, et al. Localization and expression of phospholipases A2 in Trimeresurus flavoviridis (habu snake) venom gland. Toxicon 1995; 33: 1645-52.
50. Davidson CJ, Hirt RP, Lal K, et al. Molecular evolution of the vertebrate blood coagulation network. Thromb Haemost 2003; 89: 420-8.
51. Toso R, Camire RM. Removal of B-domain sequences from factor V rather than specific proteolysis underlies the mechanism by which cofactor function is realized. J Biol Chem 2004; 279: 21643-50.
52. Ohno M, et al. Molecular evolution of snake toxins: is the functional diversity of snake toxins associated with a mechanism of accelerated evolution? Prog Nucleic Acid Res Mol Biol 1998; 59: 307-64.